Impact assessment report and executive summary accompanying the revision of the medicines for rare diseases and children legislation - European Commission
Skip to main content
European Commission logo
enen
Public Health
  • Background document

Impact assessment report and executive summary accompanying the revision of the medicines for rare diseases and children legislation